PRICE T ROWE ASSOCIATES INC /MD/ - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 75 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$111
+46.1%
16,537
+42.5%
0.00%
Q1 2023$76
-99.9%
11,601
-56.2%
0.00%
Q3 2022$140,000
-80.1%
26,500
-84.1%
0.00%
Q2 2022$705,000
-33.2%
166,200
-44.7%
0.00%
Q1 2022$1,055,000
-47.1%
300,574
+0.3%
0.00%
Q4 2021$1,996,000299,6740.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders